Tri Locum Partners LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $433 Million distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $53.4M, Zimmer Biomet Holdings, Inc. with a value of $39M, Argenx Se with a value of $35.8M, Natera, Inc. with a value of $32.1M, and Inspire Medical Systems, Inc. with a value of $28M.

Examining the 13F form we can see an increase of $58.8M in the current position value, from $374M to 433M.

Tri Locum Partners LP is based out at New York, NY

Below you can find more details about Tri Locum Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $433 Million
Healthcare: $433 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $433 Million
  • Prior Value $374 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 12 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.